Curis | CRIS - Pre Tax Profit


Curis reported $-24.2M in Pre-Tax Profit for its fiscal quarter ending in March of 2026.





Pre Tax Profit Change Date
Alaunos Therapeutics USD -7.84M 633K Dec/2023
Amgen USD 1.51B 2.41B Dec/2025
AstraZeneca USD 4.81B 894M Jun/2026
Bayer EUR -3.37B 2.21B Dec/2025
Bristol-Myers Squibb USD 4.99B 1.75B Jun/2026
CSL USD 2.61B 1.21B Dec/2025
Curis USD -24.2M 43.56M Mar/2026
Eli Lilly USD 8.27B 1.03B Dec/2025
Exelixis USD 267.69M 15M Mar/2026
Gilead Sciences USD 2.08B 1.56B Dec/2025
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Incyte USD 751.51M 407.91M Jun/2026
Merck USD 3.42B 3.32B Dec/2025
Novartis USD 4.27B 430M Jun/2026
Pfizer USD -653M 5.84B Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
Sanofi EUR 837M 1.17B Jun/2026
Takeda JPY 162.72B 215.2B Jun/2026
TG Therapeutics USD 10.23M 10.13M Jun/2026
Verastem USD -36.59M 3.68M Mar/2026